Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Inactivation of bone morphogenetic protein 2 may predict clinical outcome and poor overall survival for renal cell carcinoma through epigenetic pathways

7 Mar 2015

Abstract excerpt

// Yozo Mitsui 1,2 , Hiroshi Hirata 2 , Naoko Arichi 1 , Miho Hiraki 1 , Hiroaki Yasumoto 1 , Inik Chang 3 , Shinichiro Fukuhara 4 , Soichiro Yamamura 2 , Varahram Shahryari 2 , Guoren Deng 2 , Sharanjot Saini 2 , Shahana Majid 2 , Rajvir Dahiya 2 , Yuichiro Tanaka 2 and Hiroaki Shiina 1 1 Department of Urology, Shimane University Faculty of Medicine, Enya-cho, Izumo, Japan 2 Department of Urology, San Francisco...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Renal and related cancers
Share to Renal cell carcinoma treatment
Share to TGF-β signaling in diseases

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 25797254
DOI: 10.18632/oncotarget.3445

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 11 closest

Inactivation of bone morphogenetic protein 2 may predict clinical outcome and poor overall survival for renal cell carcinoma through epigenetic pathwaysPMID 25797254Read ↗

Molecular Mechanisms in Clear Cell Renal Cell Carcinoma: Role of miRNAs and Hypermethylated miRNA Genes in Crucial Oncogenic Pathways and ProcessesSemantic proximity Read ↗

Overexpression of BMP1 reflects poor prognosis in clear cell renal cell carcinomaSemantic proximity Read ↗

Epigenetics in renal cell cancer: mechanisms and clinical applications.Semantic proximity Read ↗

RBP2 induces stem-like cancer cells by promoting EMT and is a prognostic marker for renal cell carcinomaSemantic proximity Read ↗

OSR1 is a novel epigenetic silenced tumor suppressor regulating invasion and proliferation in renal cell carcinomaSemantic proximity Read ↗

Wnt antagonist gene polymorphisms and renal cancer.Semantic proximity Read ↗

The Dual Role of Bone Morphogenetic Proteins in CancerSemantic proximity Read ↗

ZNF471 Interacts with BANP to Reduce Tumour Malignancy by Inactivating PI3K/AKT/mTOR Signalling but is Frequently Silenced by Aberrant Promoter Methylation in Renal Cell CarcinomaSemantic proximity Read ↗

microRNA-302c-3p inhibits renal cell carcinoma cell proliferation by targeting Grb2-associated binding 2 (Gab2)Semantic proximity Read ↗

Ubiquitination Degraded BMPR2 By Smurf1 Promotes Bladder Cancer Cell GrowthSemantic proximity Read ↗

Wnt Antagonist Family Genes as Biomarkers for Diagnosis, Staging, and Prognosis of Renal Cell Carcinoma Using Tumor and Serum DNASemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.